CD274 and neoplasm: Several biomarkers reflecting the TME, such as tumor mutation burden (TMB), microsatellite instability (MSI), the density of tumor-infiltrating lymphocytes (TILs), and PD-L1 expression, have been found to correlate with the therapeutic efficacy of ICIs(Rizzo et al., 2021; Niu et al., 2022).